Research
Search
Close
XIONG Yong
- Chief Physician, Graduate Supervisor
- Department: General Surgery
- Research Area: Integrated Traditional Chinese and Western Medicine
- Research Interests: Gastrointestinal tumor therapy
- Contact: xiongyong67@163.com
- Master's Degree in Medicine from Nantong University School of Medicine, 2005
- Bachelor's Degree in Medicine from Jiangxi Medical College, 1989
- Member of Cancer Prevention Committee, China Geriatric Health Medicine Research Society
- Member of rectal cancer Committee, Chinese Medical Education Association
- Member of Shanghai Medical Association Medical expert database
- Transanal pull-through procedure with delayed versus immediate coloanal anastomosis for anus-preserving curative resection of lower rectal cancer:A case-control study. American Surgeon 2016, 80(3): 234-37.
- Ruxolitinib Inhibits the Activation of the JAK2/STAT3 Signaling Pathway and is Involved in the Regulation of the Proliferation and Migration of Human Colon Cancer Cells . Acta Medica Mediterranea, 2019, 35: 2457.
- A short deletion in the DNA binding domain of STAT3 suppresses growth and progression of colon cancer cells. Aging, 2021;13(4):5185-5196.
- 01/01/2018-12/31/2019
Seed fund of Shanghai Health Medical College, ¥20,000, 18-22-14-012
Study on the mechanism of targeted inhibition of JAK signal in the treatment of colon cancer growth and metastasis
Role: Project leader - 11/01/2017-10/31/2020
Science and Technology Development Fund of Shanghai Pudong New Area,¥240,000,2017-08
The role of IL-2/JAK2 signaling in predicting recurrence of colon cancer and targeting this signaling for colon cancer therapy.
Role: Project leader
